BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37139152)

  • 21. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma.
    Ye B; Cheng M; Li W; Ge XX; Geng JF; Feng J; Yang Y; Hu DZ
    Ann Thorac Surg; 2014 Jul; 98(1):217-23. PubMed ID: 24841547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative Folate Receptor-Positive Circulating Tumor Cells Are Associated With Occult Peritoneal Metastasis and Early Recurrence in Gastric Cancer Patients: A Prospective Cohort Study.
    Zeng CDD; Jin CC; Gao C; Xiao AT; Tong YX; Zhang S
    Front Oncol; 2022; 12():769203. PubMed ID: 35425708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.
    Zhao Y; Wang R; Shen X; Pan Y; Cheng C; Li Y; Shen L; Zhang Y; Li H; Zheng D; Ye T; Zheng S; Sun Y; Chen H
    Ann Surg Oncol; 2016 Jun; 23(6):2099-105. PubMed ID: 26842488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the diagnostic efficiency of folate receptor-positive circulating tumor cells in lung cancers: a prospective observational study.
    Liu J; Han M; Huang H
    Transl Cancer Res; 2019 Aug; 8(4):1242-1248. PubMed ID: 35116866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prognostic utility of the histologic subtype of stage I lung adenocarcinoma may be diminished when using only the invasive component to determine tumor size for tumor node metastasis (TNM) staging.
    Sung YE; Lee KY; Moon Y
    J Thorac Dis; 2021 May; 13(5):2910-2922. PubMed ID: 34164182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
    Li Z; Cai J; Zhao Y; Cai J; Zhao X
    J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Significance of Folate Receptor-positive Circulating Tumor Cells Detected by Ligand-targeted Polymerase Chain Reaction in Lung Cancer.
    Wang L; Wu C; Qiao L; Yu W; Guo Q; Zhao M; Yang G; Zhao H; Lou J
    J Cancer; 2017; 8(1):104-110. PubMed ID: 28123603
    [No Abstract]   [Full Text] [Related]  

  • 28. The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer.
    Lv X; Wu S; Xu X; Wu L; Chang N; Zhang J; Ti X
    J Thorac Dis; 2022 Jan; 14(1):158-168. PubMed ID: 35242377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of clinical results between high grade patterns in stage I lung adenocarcinoma.
    Jeon HW; Kim YD; Sim SB; Moon MH
    Thorac Cancer; 2022 Sep; 13(17):2473-2479. PubMed ID: 35820717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
    Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
    Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section.
    Zhang Y; Deng C; Fu F; Ma Z; Wen Z; Ma X; Wang S; Li Y; Chen H
    Chest; 2021 Mar; 159(3):1265-1272. PubMed ID: 33197404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathological components and CT imaging analysis of the area adjacent pleura within the pure ground-glass nodules with pleural deformation in invasive lung adenocarcinoma.
    Jiang Y; Xiong Z; Zhao W; Tian D; Zhang Q; Li Z
    BMC Cancer; 2022 Sep; 22(1):958. PubMed ID: 36068487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
    Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
    Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections.
    Trejo Bittar HE; Incharoen P; Althouse AD; Dacic S
    Mod Pathol; 2015 Aug; 28(8):1058-63. PubMed ID: 26022456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
    Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
    Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
    Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
    World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating tumor cell levels and carcinoembryonic antigen: An improved diagnostic method for lung adenocarcinoma.
    Ding C; Zhou X; Xu C; Chen J; Ju S; Chen T; Liang Z; Cui Z; Li C; Zhao J
    Thorac Cancer; 2018 Nov; 9(11):1413-1420. PubMed ID: 30178907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of lung adenocarcinoma mutation status based on histologic subtype: Retrospective analysis of 269 patients.
    Lu F; Li S; Dong B; Zhang S; Lv C; Yang Y
    Thorac Cancer; 2016 Jan; 7(1):17-23. PubMed ID: 26816535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate receptor-positive circulating tumor cells in predicting ground-glass nodules malignancy.
    Yue YS; Sun ZH; Cui Q; Jiang GZ
    Am J Transl Res; 2023; 15(4):2828-2835. PubMed ID: 37193191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective study of the relationship between the pathologic subtype and lymph node metastasis of lung adenocarcinomas of ≤3 cm diameter.
    Lin W; Huang M; Zhang Z; Chai T; Chen S; Gao L; Lin J; Kang M
    Medicine (Baltimore); 2020 Sep; 99(36):e21453. PubMed ID: 32898994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.